Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
50 results:

  • 1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. M
    Peng Y; Liu QZ; Xu D; Fu JY; Zhang LX; Qiu L; Lin JG
    Biochem Pharmacol; 2023 Nov; 217():115856. PubMed ID: 37838274
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Glioma arising in the setting of mismatch repair deficiency-rare or are we missing it?
    Goyal A; Rao S; Rishi KS; Ramaswamy V; Sadashiva N; Santosh V
    Childs Nerv Syst; 2024 Jan; 40(1):233-237. PubMed ID: 37733272
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cost-effectiveness of preventive aspirin use and intensive downstaging polypectomy in patients with familial adenomatous polyposis: A microsimulation modeling study.
    Saito E; Mutoh M; Ishikawa H; Kamo K; Fukui K; Hori M; Ito Y; Chen Y; Sigel B; Sekiguchi M; Hemmi O; Katanoda K
    Cancer Med; 2023 Sep; 12(18):19137-19148. PubMed ID: 37649281
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Lycorine promotes idh1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells.
    Zhuo FF; Li L; Liu TT; Liang XM; Yang Z; Zheng YZ; Luo QW; Lu JH; Liu D; Zeng KW; Tu PF
    Cancer Lett; 2023 Oct; 573():216364. PubMed ID: 37648148
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
    Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
    JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
    Chen J; Hong JH; Huang Y; Liu S; Yin J; Deng P; Sun Y; Yu Z; Zeng X; Xiao R; Chan JY; Guan P; Wang Y; Wang P; Liu L; Wen S; Yu Q; Ong CK; Teh BT; Xiong Y; Tan J
    Mol Cancer; 2023 May; 22(1):85. PubMed ID: 37210576
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mismatch repair-deficient glioma with spatially distinct idh-mutant and idh-wild type components arising in the setting of Lynch syndrome.
    Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Flotillin-1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment.
    Wang R; Chen Z; Zhang Y; Xiao S; Zhang W; Hu X; Xiao Q; Liu Q; Wang X
    J Cell Mol Med; 2023 Feb; 27(3):392-402. PubMed ID: 36647700
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Wild-type idh1 Knockout Leads to G0/G1 Arrest, Impairs cancer Cell Proliferation, Altering Glycolysis, and the TCA Cycle in Colon cancer.
    Atalay EB; Senturk S; Kayali HA
    Biochem Genet; 2023 Aug; 61(4):1470-1486. PubMed ID: 36633771
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive Analysis of the Prognostic Value and Molecular Function of CRNDE in Glioma at Bulk and Single-Cell Levels.
    Song L; Li X; Xu X; Huo X; Zheng Y; Wang X; Li D; Zhang J; Wang K; Wang L; Wu Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429098
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy and safety of intensive downstaging polypectomy (idp) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study.
    Takeuchi Y; Hamada K; Nakahira H; Shimamoto Y; Sakurai H; Tani Y; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Higashino K; Fujisawa F; Ezoe Y; Ishikawa H; Mutoh M; Uedo N; Nojima M; Ishihara R
    Endoscopy; 2023 Jun; 55(6):515-523. PubMed ID: 36410678
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. idh2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
    He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
    Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis (J-FAPP Study III): a multicenter prospective interventional study.
    Ishikawa H; Yamada M; Sato Y; Tanaka S; Akiko C; Tajika M; Doyama H; Takayama T; Ohda Y; Horimatsu T; Sano Y; Tanakaya K; Ikematsu H; Saida Y; Ishida H; Takeuchi Y; Kashida H; Kiriyama S; Hori S; Lee K; Tashiro J; Kobayashi N; Nakajima T; Suzuki S; Mutoh M;
    Endoscopy; 2023 Apr; 55(4):344-352. PubMed ID: 36216266
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prevalence of Molecular Alterations in a Swiss Cohort of 512 colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics.
    Haefliger S; Marston K; Alborelli I; Stauffer EJ; Gugger M; Jermann PM; Hoeller S; Tornillo L; Terracciano LM; Bihl M; Matter MS
    Pathobiology; 2023; 90(3):166-175. PubMed ID: 36202073
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
    Kim H; Lim KY; Park JW; Kang J; Won JK; Lee K; Shim Y; Park CK; Kim SK; Choi SH; Kim TM; Yun H; Park SH
    Lab Invest; 2022 Feb; 102(2):160-171. PubMed ID: 34848827
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population.
    MacDonald S; MacDonald L; Godwin J; Macdonald A; Thornton M
    Colorectal Dis; 2022 Mar; 24(3):257-263. PubMed ID: 34797583
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cancer-associated idh mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.
    Liu X; Yamaguchi K; Takane K; Zhu C; Hirata M; Hikiba Y; Maeda S; Furukawa Y; Ikenoue T
    PLoS One; 2021; 16(9):e0257090. PubMed ID: 34516556
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Wild-type idh2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.
    Qiao S; Lu W; Glorieux C; Li J; Zeng P; Meng N; Zhang H; Wen S; Huang P
    Oncogene; 2021 Sep; 40(39):5880-5892. PubMed ID: 34349242
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. DNMT1 Mediated CAHM Repression Promotes Glioma Invasion via SPAK/JNK Pathway.
    Xu Y; Li Z; Huai T; Huo X; Wang H; Bian E; Zhao B
    Cell Mol Neurobiol; 2022 Nov; 42(8):2643-2653. PubMed ID: 34227028
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.